MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Phase 2 Recruiting
2,000 enrolled
Home-based Respiratory Muscle Training for Minimizing Side Effects in Patients Undergoing Treatment for Breast Cancer
Phase NA Recruiting
130 enrolled
MK-3475-587
Phase 3 Recruiting
3,500 enrolled
I-SPY
Phase 2 Recruiting
5,000 enrolled
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Phase 2 Recruiting
140 enrolled
EMPOWER
Phase NA Recruiting
100 enrolled
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
Phase 1 Recruiting
800 enrolled
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Phase 2/3 Recruiting
430 enrolled
Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia
Phase 1/2 Recruiting
70 enrolled
A Tool for Improving the Shared Decision-making Process in Patients With Non-small Cell Lung Cancer
Phase NA Recruiting
100 enrolled
Telehealth Intervention for Ostomy Self-Management
Phase 2 Recruiting
150 enrolled
Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene Interactions
Phase NA Recruiting
1,300 enrolled
Phase 2 Trial of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab in Patients With Newly Diagnosed PD-L1 CPS Positive Resectable Stage 3-4 Oral Cavity Squamous Cell Carcinoma (OCSCC).
Phase 2 Recruiting
29 enrolled
A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and Upper Tract Urothelial Cancer, Get Moving Trial
Phase NA Recruiting
128 enrolled
Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)
Phase NA Recruiting
760 enrolled
[18F]FTT Positron Emission Tomography for the Measurement of PARP Tumor Expression in Patients With Metastatic Breast Cancer
Phase 1/2 Recruiting
22 enrolled
TulmiSTAR-01
Phase 1/2 Recruiting
188 enrolled
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
Phase 3 Recruiting
1,780 enrolled
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
Phase 2 Recruiting
145 enrolled
Evaluating a Mobile Health Application Intervention for Caregiver Instruction in Manual Therapy for Chemotherapy-Induced Peripheral Neuropathy
Phase NA Recruiting
300 enrolled
Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma
Phase 3 Recruiting
369 enrolled
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
Phase 3 Recruiting
60 enrolled
AcTFirst
Phase 3 Recruiting
940 enrolled
BLCIO
Phase NA Recruiting
3,584 enrolled
Parenting Support Intervention for Families Coping With Metastatic or Locally Recurrent Solid Tumor Diagnosis
Phase NA Recruiting
120 enrolled
REGOSTA
Phase NA Recruiting
168 enrolled
Virtual Reality 3D-Surgery Modeling to Enhance Head and Neck Cancer Surgery Quality
Phase NA Recruiting
160 enrolled
Olanzapine for Managing Anorexia in Head and Neck Cancer Patients Undergoing Chemoradiation, MACRO Trial
Phase 2 Recruiting
66 enrolled
CHIC-STS01
Phase 3 Recruiting
600 enrolled
High-Fermented Food Intervention Among Locally Advanced Rectal Cancer Patients (The FEED Trial)
Phase NA Recruiting
54 enrolled
A Clinic-wide Intervention (Primary Care-GI Connect) for Improving Rates of Colonoscopy After Abnormal Fecal Immunochemical Test Result in Patients at Federally Qualified Health Centers
Phase NA Recruiting
1,500 enrolled
Risk-adapted, Proteomic-guided Systemic Therapy for Previously Untreated Advanced Non-small Cell Lung Cancer
Phase 2 Recruiting
56 enrolled
MOTIVATE
Phase NA Recruiting
30 enrolled
ID-COMET
Phase 3 Recruiting
800 enrolled
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Phase 2 Recruiting
98 enrolled
Solution-Focused Brief Therapy for Support of Psychological Distress in Adolescent and Young Adult Cancer Survivors
Phase NA Recruiting
60 enrolled
Studying Quality of Life Inclusive of Mental Health and Cognitive Behavioral Therapy for Cancer Distress for the Improvement of Quality of Life in Stage III-IV Melanoma Patients
Phase NA Recruiting
350 enrolled
Digital Health Intervention for Self-Management and Telemonitoring in Chimeric Antigen Receptor (CAR-T) Therapy
Phase 3 Recruiting
190 enrolled
Oral Cryotherapy to Decrease Taste Changes in Prostate Cancer Patients Receiving Taxane Chemotherapy
Phase NA Recruiting
60 enrolled
ONC-MM-2407: The Effect of Virtual Reality Headsets on Pain and Anxiety in the Peri and Post Bone Marrow Biopsy Period
Phase NA Recruiting
160 enrolled
Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer
Phase NA Recruiting
80 enrolled
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Phase 2/3 Recruiting
694 enrolled
eReach2
Phase NA Recruiting
1,000 enrolled
Virtual Reality Headset and/or Aromatherapy for Patients Undergoing a Transperineal Prostate Biopsy
Phase NA Recruiting
208 enrolled
Patient Navigation and the Planning Advance Care Together Website to Improve Goals of Care Conversations in Hematopoietic Cell Transplant Survivors, IMPACT-HCT Trial
Phase NA Recruiting
40 enrolled
GEM-S
Phase 3 Recruiting
668 enrolled
CoGENES Randomized Controlled Trial (RCT)
Phase NA Recruiting
140 enrolled
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
Phase 1 Recruiting
72 enrolled
PNOC031
Phase 2 Recruiting
70 enrolled
CHUQUL_HO001
Phase 4 Recruiting
80 enrolled